"Pharmaceutical headlinejun" 11 hundred billion market value pharmaceutical companies assembled A shares! Hengrui and others surged by more than 100 billion yuan.

(2020/07/16) Considine's IPO approval will welcome the first A-H vaccine stocks; private hospitals have made a big effort to combat the epidemic in the city but why there is widespread anxiety after the outbreak; and a correct understanding of "hydroxychloroquine" rheumatoid immunity is where it is used... (Click on the title, can get the original text) (Pharmaceutical 1st time) Consino's IPO approval of the science and technology board will welcome the first A-H vaccine shares on July 15, the CSRC issued a number of enterprises, including The Company's IPO approval, including Consino Bio.
Consino Bio was listed on the Hong Kong Stock Exchange in March 2019, meaning that if the listing is successful, the company will become the first A-share "A-H" vaccine stock.
headlines: Considine Bio is known for its leading position in the development of new vaccines worldwide.
" eight-point health news" private hospital in the city anti-epidemic neutral work, but after the outbreak why general anxiety? Experienced SARS, experienced influenza, avian influenza, hand, foot and mouth disease, baby milk powder incident ... Of all the major public health incidents of the past 20 years, Cebu has not lost its chain.
private hospitals are very obedient to management, never as said outside, said that private hospitals only know profit-sane, can not be mobilized.
headlines: private hospitals as active as public hospitals.
.Mnet.com 11 billion-dollar drug companies assembled A-shares! Heng Rui, Murray... Surge of more than 100 billion today, The three major A-share indexcollective fell, the industry sector fell across the board.
in fact, since this year, pharmaceutical stocks continued to rise, Hengrui Pharmaceuticals, Pharmaceutical Mingkang, Changchun High-tech, Huahai Pharmaceuticals and many other pharmaceutical stocks hit new highs.
as of the close of trading on July 16, Hengrui Pharmaceuticals, Changchun High-tech, and the 11 pharmaceutical stocks were worth more than 100 billion yuan.
headline: There are only five pharmaceutical stocks with a market capitalization of 100 billion in 2019.
medicine, correct understanding of "hydroxychloroquine" rheumatism immunity is its use! On June 4, 2020, a previously published paper on hydroxychloroquine in The Lancet was withdrawn, and instantaneous public opinion pointed to Surgisphere's alleged falsification of data, and the suspension of the WHO hydroxychloroquine clinical trial at the end of May, a time for hydroxyl chloroquine was once again pushed to the forefront of the wind... Headline bacteria: Hydroxychloroquine can also accumulate in the body and bind to double-stranded DNA.
The Pharmaceutical Rubik's Cube CD3 Double Anti-Entry Solid Tumor: The International Multicenter Clinical Trial of Catumaxmab, the world's first T cell engager bispecific antibody drug, will be launched in the near future, and catumaxmab, the world's first T cell engaged bispecific antibody drug, has been approved by the China Drug Administration (NMPA), the Taiwan Ministry of Health and Welfare (MOHW) and the Korea Food and Drug Administration (MFDS) in clinical trials to develop gastric cancer.
headline: The recurrence of peritoneal metastasis is one of the leading causes of death from advanced stomach cancer.
.